GlassScriptPhysician profile
Arlene A Hallegado
NPI 1982794012
$3,119.39
in general payments reported to CMS, 2019-2025
34 companies · $61.36 in 2025
The $61.36 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,251 · 2020: $308 · 2021: $456 · 2022: $473 · 2023: $571 · 2025: $61.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $579.92 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $409.60 | 2019-2025 | Wegovy, Ozempic |
| Merck Sharp & Dohme LLC | $255.91 | 2019-2023 | Verquvo, Steglatro, Belsomra |
| Lilly USA, LLC | $227.77 | 2019-2023 | Jardiance, Emgality, Mounjaro |
| Amgen INC. | $201.98 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.78 | 2019-2023 | Xifaxan, Trulance |
| Abbvie INC. | $170.14 | 2022-2023 | |
| Glaxosmithkline, LLC. | $142.35 | 2021-2023 | Trelegy Ellipta |
| Pfizer INC. | $116.10 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $83.93 | 2019 | |
| Boston Scientific Corporation | $76.35 | 2022 | |
| Grifols USA, LLC | $75.91 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.92 | 2019-2022 | |
| Exact Sciences Corporation | $60.49 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Currax Pharmaceuticals LLC | $48.59 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $48.47 | 2019-2022 | |
| Medtronic, INC. | $42.22 | 2023 | Intellis Adaptivestim |
| Arbor Pharmaceuticals, INC. | $40.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.13 | 2023 | |
| Eisai INC. | $35.25 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.12 | 2022 | |
| Ironwood Pharmaceuticals, INC | $22.74 | 2019-2020 | |
| Si-Bone, INC. | $22.68 | 2023 | |
| Sanofi-Aventis U.S. LLC | $18.82 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $15.73 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.63 | 2021 | |
| Astellas Pharma US INC | $15.11 | 2023 | Myrbetriq |
| Abbott Laboratories | $12.77 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.75 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.29 | 2022 | |
| Gilead Sciences, INC. | $11.76 | 2019 | |
| Allergan, INC. | $11.62 | 2019 | |
| Amarin Pharma, INC. | $11.09 | 2021 | |
| Ironshore Pharmaceuticals INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Hallegado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.